S. 3797: Prohibiting Tianeptine and Other Dangerous Products Act of 2026

This bill, titled the Prohibiting Tianeptine and Other Dangerous Products Act of 2026, aims to enhance regulations around dietary supplements by making specific amendments to the Federal Food, Drug, and Cosmetic Act. Here are the key provisions of the bill:

Prohibited Acts

• The bill introduces new prohibited acts regarding dietary supplements, specifically:
  • It prohibits the introduction or delivery of any product marketed as a dietary supplement if it does not meet the statutory definition of a dietary supplement.
  • It also makes it illegal to introduce or deliver any dietary supplement that has been prepared, packed, or held with the assistance of an individual who has been debarred from such activities.

Import Exclusions

The legislation updates the import exclusion section so that products violating the new prohibited acts can be rejected from entering the United States. This essentially means that if a dietary supplement falls under the new prohibitions outlined in the bill, it cannot be imported into the country.

Seizure Authorities

The bill also expands the seizure authorities of the Food and Drug Administration (FDA) regarding dietary supplements. This includes:

• Allowing the FDA to seize products that violate the new regulations defined in paragraphs (jjj) and (kkk) of section 301.
• Updating references in the law that govern the FDA’s authority to condemn and seize products that do not comply with the new provisions.

Conclusion

Overall, this legislation seeks to establish stricter control over the dietary supplement market, specifically targeting products that may be harmful or misrepresented.

Relevant Companies

• None found